HDAC-IN-4
HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor with pIC50s of 7.2 and 6.8 in BRET assay, respectively. Antitumoral activity[1].
Product Specifications
CAS Number
1252003-13-6
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-4-1.html
Purity
98.00
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NO)C1=CC=C(CN2C(CN(C)CC3)=C3C4=C2C=CC=C4)C=C1
Molecular Formula
C20H21N3O2
Molecular Weight
335.40
References & Citations
[1]Géraldy M, et al. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated. J Med Chem. 2019 May 9;62 (9) :4426-4443.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP320057M 100 µg
Retinal S antigen (SAG) (NM_000541) Human Recombinant Protein
Sign In for Pricing
View Details 
BNC403196-100 1x 100 µL
PAX8 (Renal Cell Marker) (rPAX8/1492), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details